Lumican (LUM) and mimecan (OGN), which were exclusively related to Stage II IPF patients, are small leucine-rich proteoglycan (SLRP) families of proteins that represent key components of the ECM. This evidence concerns the gene OGN and idiopathic pulmonary fibrosis.